Skip to content
Mobidiag
Mobidiag
Enabling faster, more accessible molecular diagnostics
  • Home
  • Contact Us

Posts

Diagnostic Microbiology and Infectious Disease

December 19, 2019

2019 Prospective evaluation of the Amplidiag® CarbaR+VRE assay for direct
screening of carbapenemase producing gram-negative bacilli from
rectal swabs

Share on: Share on FacebookShare on LinkedinShare on Twitter
Posted in: Publications

Post navigation

← Mobidiag Symposium on Innovative Molecular Diagnostics to be held for Third year at RICAI Annual Meeting
Diagnostic Microbiology and Infectious Disease →
  • Home
  • Contact Us
  • Cookie Policy (EU)


©2023 Hologic, Inc. All rights reserved.
Hologic, Mobidiag, Novodiag and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. All other trademarks, registered trademarks, and product names are the property of their respective owners.
Learn more about our Privacy policy.
Top